Old hopes and new horizons for treating cystic fibrosis.
Featherstone
C
C
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003550:Cystic Fibrosis / Q000628:therapy*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics; D015316:Genetic Therapy; D006801:Humans; D008081:Liposomes; D014031:Tobramycin / Q000627:therapeutic use; D014544:Uridine Triphosphate / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; C505032:CFTR protein, human; D008081:Liposomes; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D014544:Uridine Triphosphate; D014031:Tobramycin